These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3311437)

  • 41. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K
    Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
    [No Abstract]   [Full Text] [Related]  

  • 42. Fansidar-resistant falciparum malaria in Papua New Guinea.
    Nurse GT
    Lancet; 1981 Jan; 1(8210):36-7. PubMed ID: 6109064
    [No Abstract]   [Full Text] [Related]  

  • 43. Stage-specific sensitivity of Plasmodium falciparum to antifolates.
    Dieckmann A; Jung A
    Z Parasitenkd; 1986; 72(5):591-4. PubMed ID: 3535282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa.
    Timmermanns PM; Hess U; Jones ME
    Lancet; 1982 May; 1(8282):1181. PubMed ID: 6122952
    [No Abstract]   [Full Text] [Related]  

  • 45. Fansidar resistant falciparum malaria in Indonesia.
    Rumans LW; Dennis DT; Atmosoedjono S
    Lancet; 1979 Sep; 2(8142):580-1. PubMed ID: 89577
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug-resistant malaria.
    Lancet; 1981 Nov; 2(8255):1087-8. PubMed ID: 6118530
    [No Abstract]   [Full Text] [Related]  

  • 47. [Resistance of Plasmodium falciparum to fansidar, quinine and tetracycline].
    Alencar FH; Ferraroni JJ; Shrimpton R
    Rev Saude Publica; 1982 Oct; 16(5):299-302. PubMed ID: 6762641
    [No Abstract]   [Full Text] [Related]  

  • 48. Fansidar-resistant falciparum malaria in Papua New Guinea.
    Darlow B; Vrbova H; Stace J; Heywood P; Aalpers M
    Lancet; 1980 Dec; 2(8206):1243. PubMed ID: 6108409
    [No Abstract]   [Full Text] [Related]  

  • 49. Plasmodium falciparum RI resistance to quinine and sulphadoxine-pyrimethamine in the Solomon Islands.
    Isaacs RD; Ellis-Pegler RB
    Med J Aust; 1987 Apr; 146(8):449-50. PubMed ID: 3302637
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chloroquine- and fansidar-resistant falciparum malaria treated with minocycline].
    Ferraroni JJ
    Rev Saude Publica; 1983 Aug; 17(4):328-31. PubMed ID: 6361974
    [No Abstract]   [Full Text] [Related]  

  • 51. [Studies on the sensitivity of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in vitro].
    Han XL; Liu DQ; Feng XP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):8-10. PubMed ID: 12567461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid.
    Watkins WM; Sixsmith DG; Chulay JD; Spencer HC
    Mol Biochem Parasitol; 1985 Jan; 14(1):55-61. PubMed ID: 3885030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.
    Sirawaraporn W; Yuthavong Y
    Antimicrob Agents Chemother; 1986 May; 29(5):899-905. PubMed ID: 3729346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmodium falciparum: variations in p-aminobenzoic acid requirements as related to sulfadoxine sensitivity.
    Tan-Ariya P; Brockelman CR
    Exp Parasitol; 1983 Jun; 55(3):364-71. PubMed ID: 6343109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting.
    Weidekamm E; Plozza-Nottebrock H; Forgo I; Dubach UC
    Bull World Health Organ; 1982; 60(1):115-22. PubMed ID: 6979415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility of Thai isolates of Plasmodium falciparum to artemisinine (qinghaosu) and artemether.
    Thaithong S; Beale GH
    Bull World Health Organ; 1985; 63(3):617-9. PubMed ID: 3899399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance.
    Wang P; Sims PF; Hyde JE
    Parasitology; 1997 Sep; 115 ( Pt 3)():223-30. PubMed ID: 9300459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Inhibitory effect of artemisinine-sulfadoxine-pyrimethamine combination on the development of drug-resistance in Plasmodium berghei].
    Zhou YQ; Ning DX
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):453-7. PubMed ID: 3064550
    [No Abstract]   [Full Text] [Related]  

  • 59. Susceptibility of in vitro cultured Plasmodium falciparum to chloroquine and combination of sulfadoxine and pyrimethamine.
    Keittivuti B; Keittivuti A; Panichacheewakul P
    Int J Parasitol; 1982 Oct; 12(5):383-7. PubMed ID: 6754642
    [No Abstract]   [Full Text] [Related]  

  • 60. Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
    Timm U; Weidekamm E
    J Chromatogr; 1982 Jun; 230(1):107-14. PubMed ID: 6980889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.